Design, characterization, and validation of a high-affinity synthetic peptide as bioreceptor for label-free detection of prostate specific antigen., PMID:40505236
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study., PMID:40485573
Combined treatment with anti-PSMA antibody and human peripheral blood-derived NK cells for castration-resistant prostate cancer., PMID:40469300
PSMA targeted Therapy: From molecular mechanisms to clinical breakthroughs in castration-resistant prostate cancer., PMID:40466338
High-Efficiency Detection of Total-PSA and Free-PSA in Whole Blood by Microfluidic Chip Integrated with Electromagnetic Co-Preprocessing., PMID:40456626
Serum immunoreactivity to neurofilament-medium shows high sensitivity and specificity in patients with Behçet disease., PMID:40447321
Anti-PCNA antibodies in psoriatic arthritis: a case-control study., PMID:40417241
Real-world safety assessment of Ixekizumab based on the FDA Adverse Event Reporting System (FAERS)., PMID:40408459
Trastuzumab deruxtecan versus trastuzumab emtansine for human epidermal growth factor receptor 2 positive metastatic breast cancer: cost-effectiveness analysis from Iranian experience., PMID:40380283
Intracerebral hemorrhage (hemorrhagic stroke) secondary to Bothrops spp. snakebite envenomation in a horse., PMID:40379034
Precision Assay for Detection and Quantification of Anti-Prostate Specific Antigen Antibodies Using Indirect ELISA., PMID:40377158
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study., PMID:40376617
Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learning., PMID:40367245
[Efficient capture and proteomics analysis of urinary extracellular vesicles by affinity purification]., PMID:40331614
Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy Compared with Chemotherapy as First-Line Treatment for Advanced PD-L1-Positive Triple-Negative Breast Cancer from a Japanese Healthcare Perspective., PMID:40317386
Polarity-Switchable Dual-Mode Photoelectrochemical Cancer Marker Immunoassay Based on a Metal-Organic Framework@Nitrogen-Doped Graphdiyne Heterojunction., PMID:40304230
Over-expression of Truncated IK Ameliorates Dinitrochlorobenzene-Induced Allergic Contact Dermatitis Lesions in BALB/c Mice., PMID:40294983
PD - L1 (SP263) expression correlates with pathological aggressive parameters in prostate cancer., PMID:40273724
The nature of the post-translational modifications of the autoantigen LL37 influences the autoreactive T-helper cell phenotype in psoriasis., PMID:40270954
Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients., PMID:40270010
Cost-effectiveness analysis of regorafenib dose optimization for refractory metastatic colorectal cancer., PMID:40265856
What are mice teaching us about psoriatic arthritis?, PMID:40265275
PRL2 negatively regulates FcεRI mediated activation of mast cells., PMID:40258807
High long-term retention rates of Secukinumab in psoriatic arthritis and ankylosing spondylitis: a 3-year interim analysis from the observational, prospective SERENA study, in Greek patients., PMID:40249514
Bioconjugates of photon-upconversion nanoparticles with antibodies for the detection of prostate-specific antigen and p53 in heterogeneous and homogeneous immunoassays., PMID:40231544
Integration of Carboxylate Carbon Dot-Supported Gold Nanoparticles with Boron Nitride Nanosheets for Electrochemical Sensing of Prostate-Specific Antigen via Sandwich Immunoassays., PMID:40228088
Electrochemical immunoplatform for the quantification of epithelial extracellular vesicles applied to prostate cancer diagnosis., PMID:40222093
Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies., PMID:40194794
Real-world safety and effectiveness of guselkumab in patients with psoriasis: A post-marketing surveillance study through up to week 52 in Japan., PMID:40156259
A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma., PMID:40145367
In silico maturation of DNA aptamer against the prostate-specific antigen (PSA) and kinetic analysis., PMID:40132516
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial., PMID:40102973
Copper-doped NH2-metal-organic frameworks as co-reactant modulating units for a sensitive electrochemiluminescence immunoassay., PMID:40091652
A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral responses., PMID:40087280
From the Masterclasses in Dermatology 2024 Meeting: Updates in Psoriasis Treatments., PMID:40078858
Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177Lu-based Radioimmunotherapy of Lung Cancer., PMID:40078313
Bimekizumab in the Treatment of Axial Spondyloarthritis and Psoriatic Arthritis: A New Kid on the Block., PMID:40076933
Targeting IL-23 in Psoriatic Arthritis: A Review of Guselkumab's Efficacy and Utilization., PMID:40073332
Response to pembrolizumab in advanced prostate cancer with predictive biomarkers., PMID:40063607
Gold Nanoparticle Incorporated Graphene Oxide as a SERS Platform for Ultratrace Antibody Free Sensing of the Cancer Biomarker CEA., PMID:40062598
Integrated Device for Cancer Nucleic Acid Biomarker Detection at Body Temperature., PMID:40047709
The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations., PMID:40019616
The safety assessment of ustekinumab on psoriasis and psoriatic arthritis: A real-world analysis based on the FDA adverse event reporting system database., PMID:39987634
Sequential biologic therapy in the treatment of active psoriatic arthritis in China: a cost-effectiveness analysis., PMID:39982592
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer., PMID:39964352
Anti-citrullinated protein antibody detection by hemagglutination., PMID:39959134
Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis., PMID:39945386
FGF7 as an essential mediator for the onset of ankylosing enthesitis related to psoriatic dermatitis., PMID:39919800
Two-Dimensional Polymer Films as a Suitable Platform to Covalent Graft Antibody Receptors in an Electrolyte-Gated Organic Field Effect Transistor Bioassay., PMID:39915087
Antinuclear Antibodies Staining Patterns and Titers in Juvenile Idiopathic Arthritis., PMID:39901832
For research use only. Not for human or drug use.
